Cart
sales@molnova.com
Xanthotoxol
CAS No. 2009-24-7
Xanthotoxol( 8-Hydroxypsoralen )
Catalog No. M18201 CAS No. 2009-24-7
Xanthotoxol exhibits dose-graded sedative activity in dogs, cats, rats, mice and hamsters. Xanthotoxol at concentrations of 5 to 5 micrograms/ml inhibits the growth of cells, decreases amount of cell protein, mitotic index.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 35 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 49 | In Stock |
|
| 25MG | 74 | In Stock |
|
| 50MG | 100 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXanthotoxol
-
NoteResearch use only, not for human use.
-
Brief DescriptionXanthotoxol exhibits dose-graded sedative activity in dogs, cats, rats, mice and hamsters. Xanthotoxol at concentrations of 5 to 5 micrograms/ml inhibits the growth of cells, decreases amount of cell protein, mitotic index.
-
DescriptionXanthotoxol exhibits dose-graded sedative activity in dogs, cats, rats, mice and hamsters. Xanthotoxol at concentrations of 5 to 5 micrograms/ml inhibits the growth of cells, decreases amount of cell protein, mitotic index. Xanthotoxol has neuroprotection, due to the ability of xanthotoxol to attenuate the expression of pro-inflammatory mediators and thereby inhibit the inflammatory response after cerebral ischemia.
-
In Vitro——
-
In Vivo——
-
Synonyms8-Hydroxypsoralen
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number2009-24-7
-
Formula Weight202.16
-
Molecular FormulaC11H6O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : 123 mg/mL; 608.43 mM
-
SMILESC1=CC(=O)OC2=C(C3=C(C=CO3)C=C21)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CX08005
CX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
-
MLS000544460
MLS000544460 is a highly selective and reversible Eya2 phosphatase inhibitor (Kd: 2.0 μM, IC50: 4 μM) that exhibits inhibitory effects on Eya2 phosphatase-mediated cell migration and has anticancer activity.
-
JAB-3068
JAB-3068 (SHP2-IN-6) is a potent SHP2 inhibitor exhibiting anticancer and antitumor properties, designed for research in breast, lung, and esophageal cancers.
